The way forward for Ketamine and Mood Disorders In 2019, the FDA and European Fee authorised using an esketamine nasal spready underneath the brand name Spravato to treat melancholy. Nevertheless, as of 2021, ketamine hasn't been approved because of the FDA to treat depression or other psychological health and fitness https://josuewacdd.thenerdsblog.com/35455250/the-2-minute-rule-for-lsd-sheets